180 related articles for article (PubMed ID: 33302429)
1. Interrogation of
Cameron JM; Conn JJA; Rinaldi C; Sala A; Brennan PM; Jenkinson MD; Caldwell H; Cinque G; Syed K; Butler HJ; Hegarty MG; Palmer DS; Baker MJ
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33302429
[TBL] [Abstract][Full Text] [Related]
2. Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the
Uckermann O; Juratli TA; Galli R; Conde M; Wiedemuth R; Krex D; Geiger K; Temme A; Schackert G; Koch E; Steiner G; Kirsch M
Clin Cancer Res; 2018 Jun; 24(11):2530-2538. PubMed ID: 29259030
[No Abstract] [Full Text] [Related]
3. Isocitrate Dehydrogenase 1 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
J Comp Pathol; 2018 Nov; 165():33-39. PubMed ID: 30502793
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
[TBL] [Abstract][Full Text] [Related]
5. Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates.
Bernabéu-Sanz Á; Fuentes-Baile M; Alenda C
Eur Radiol; 2021 Feb; 31(2):749-763. PubMed ID: 32875375
[TBL] [Abstract][Full Text] [Related]
6. Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
Kloosterhof NK; Bralten LB; Dubbink HJ; French PJ; van den Bent MJ
Lancet Oncol; 2011 Jan; 12(1):83-91. PubMed ID: 20615753
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the occurrence rates of
Cho U; Yang SH; Yoo C
J Int Med Res; 2021 Jun; 49(6):3000605211019258. PubMed ID: 34162262
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of IDH1 mutations in gliomas by high resolution melting analysis, immunohistochemistry and direct DNA sequencing.
Li J; Zhang H; Wang L; Yang C; Lai H; Zhang W; Chen X; Wang J
Mol Med Rep; 2015 Sep; 12(3):4376-4381. PubMed ID: 26130305
[TBL] [Abstract][Full Text] [Related]
9. IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy.
Uckermann O; Yao W; Juratli TA; Galli R; Leipnitz E; Meinhardt M; Koch E; Schackert G; Steiner G; Kirsch M
J Neurooncol; 2018 Sep; 139(2):261-268. PubMed ID: 29761368
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of PET/CT with
Ogawa T; Kawai N; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T
EJNMMI Res; 2020 May; 10(1):44. PubMed ID: 32382870
[TBL] [Abstract][Full Text] [Related]
11. Spectrochemical differentiation of meningioma tumours based on attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy.
Lilo T; Morais CLM; Ashton KM; Pardilho A; Davis C; Dawson TP; Gurusinghe N; Martin FL
Anal Bioanal Chem; 2020 Feb; 412(5):1077-1086. PubMed ID: 31865413
[TBL] [Abstract][Full Text] [Related]
12. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
[TBL] [Abstract][Full Text] [Related]
13. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H
Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
Jain S; Gupta P; Shankar KB; Singh R; Siraj F
J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Study Between Tumor Blood Vessels and Dynamic Contrast-enhanced MRI for Identifying Isocitrate Dehydrogenase Gene 1 (IDH1) Mutation Status in Glioma.
Li SH; Shen NX; Wu D; Zhang J; Zhang JX; Jiang JJ; Zhu WZ
Curr Med Sci; 2022 Jun; 42(3):650-657. PubMed ID: 35606665
[TBL] [Abstract][Full Text] [Related]
16. Development of a Rapid and Sensitive IDH1/2 Mutation Detection Method for Glial Tumors and a Comparative Mutation Analysis of 236 Glial Tumor Samples.
Avsar T; Sursal A; Turan G; Yigit BN; Altunsu D; Cantasir K; Duyu G; Bayoumi AB; Yapicier O; Acar M; Kilic T
Mol Diagn Ther; 2020 Jun; 24(3):327-338. PubMed ID: 32274701
[TBL] [Abstract][Full Text] [Related]
17. Stratifying Brain Tumour Histological Sub-Types: The Application of ATR-FTIR Serum Spectroscopy in Secondary Care.
Cameron JM; Rinaldi C; Butler HJ; Hegarty MG; Brennan PM; Jenkinson MD; Syed K; Ashton KM; Dawson TP; Palmer DS; Baker MJ
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32605100
[TBL] [Abstract][Full Text] [Related]
18. Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients.
Barritault M; Picart T; Poncet D; Fenouil T; d'Hombres A; Gabut M; Guyotat J; Jouanneau E; Ameli R; Joubert B; Streichenberger N; Vasiljevic A; Honnorat J; Meyronet D; Ducray F
Neurosurgery; 2020 Sep; 87(4):E513-E519. PubMed ID: 32107549
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
20. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
Weller M; Weber RG; Willscher E; Riehmer V; Hentschel B; Kreuz M; Felsberg J; Beyer U; Löffler-Wirth H; Kaulich K; Steinbach JP; Hartmann C; Gramatzki D; Schramm J; Westphal M; Schackert G; Simon M; Martens T; Boström J; Hagel C; Sabel M; Krex D; Tonn JC; Wick W; Noell S; Schlegel U; Radlwimmer B; Pietsch T; Loeffler M; von Deimling A; Binder H; Reifenberger G
Acta Neuropathol; 2015 May; 129(5):679-93. PubMed ID: 25783747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]